Adenylosuccinic acid: a novel inducer of the cytoprotectant Nrf2 with efficacy in Duchenne muscular dystrophy.
Duchenne muscular dystrophy
Nrf2
adenylosuccinic acid
therapeutics
Journal
Current medical research and opinion
ISSN: 1473-4877
Titre abrégé: Curr Med Res Opin
Pays: England
ID NLM: 0351014
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
pubmed:
18
12
2020
medline:
16
10
2021
entrez:
17
12
2020
Statut:
ppublish
Résumé
Adenylosuccinic acid (ASA) modifies Duchenne muscular dystrophy (DMD) progression in dystrophic
Identifiants
pubmed: 33331789
doi: 10.1080/03007995.2020.1865699
doi:
Substances chimiques
NF-E2-Related Factor 2
0
adenylosuccinate
19240-42-7
Adenosine Monophosphate
415SHH325A
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM